These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 12384316)
1. Toxicity, biodegradation and elimination of polyanhydrides. Katti DS; Lakshmi S; Langer R; Laurencin CT Adv Drug Deliv Rev; 2002 Oct; 54(7):933-61. PubMed ID: 12384316 [TBL] [Abstract][Full Text] [Related]
2. In vivo and in vitro elimination of aliphatic polyanhydrides. Domb AJ; Nudelman R Biomaterials; 1995 Mar; 16(4):319-23. PubMed ID: 7772672 [TBL] [Abstract][Full Text] [Related]
6. Bioerodible polyanhydrides as drug-carrier matrices. I: Characterization, degradation, and release characteristics. Leong KW; Brott BC; Langer R J Biomed Mater Res; 1985 Oct; 19(8):941-55. PubMed ID: 3880353 [TBL] [Abstract][Full Text] [Related]
7. Polyanhydrides. V. Branched polyanhydrides. Maniar M; Xie XD; Domb AJ Biomaterials; 1990 Nov; 11(9):690-4. PubMed ID: 2090304 [TBL] [Abstract][Full Text] [Related]
8. Surface and bulk modifications to photocrosslinked polyanhydrides to control degradation behavior. Burkoth AK; Burdick J; Anseth KS J Biomed Mater Res; 2000 Sep; 51(3):352-9. PubMed ID: 10880076 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of Aliphatic Polyanhydrides with Controllable and Reproducible Molecular Weight. Ghosh R; Arun Y; Siman P; Domb AJ Pharmaceutics; 2022 Jul; 14(7):. PubMed ID: 35890298 [TBL] [Abstract][Full Text] [Related]
10. Bioerodible polyanhydrides as drug-carrier matrices. II. Biocompatibility and chemical reactivity. Leong KW; D'Amore PD; Marletta M; Langer R J Biomed Mater Res; 1986 Jan; 20(1):51-64. PubMed ID: 3949823 [TBL] [Abstract][Full Text] [Related]
12. Role of polyanhydrides as localized drug carriers. Jain JP; Modi S; Domb AJ; Kumar N J Control Release; 2005 Apr; 103(3):541-63. PubMed ID: 15820403 [TBL] [Abstract][Full Text] [Related]
13. Polyanhydrides: an overview. Kumar N; Langer RS; Domb AJ Adv Drug Deliv Rev; 2002 Oct; 54(7):889-910. PubMed ID: 12384314 [TBL] [Abstract][Full Text] [Related]
15. Polyanhydrides for controlled release of bioactive agents. Leong KW; Kost J; Mathiowitz E; Langer R Biomaterials; 1986 Sep; 7(5):364-71. PubMed ID: 3778996 [TBL] [Abstract][Full Text] [Related]
16. The development of polyanhydrides for drug delivery applications. Tamada J; Langer R J Biomater Sci Polym Ed; 1992; 3(4):315-53. PubMed ID: 1350734 [TBL] [Abstract][Full Text] [Related]
17. Degradation and drug delivery properties of poly(1,4-cyclohexanedicarboxylic anhydride). Zhang T; Gu M; Yu X J Biomater Sci Polym Ed; 2001; 12(5):491-501. PubMed ID: 11469780 [TBL] [Abstract][Full Text] [Related]
19. In vivo degradation and biocompatibility of a new class of alternate poly(ester-anhydrides) based on aliphatic and aromatic diacids. Jiang HL; Tang GP; Weng LH; Zhu KJ J Biomater Sci Polym Ed; 2001; 12(12):1281-92. PubMed ID: 11922475 [TBL] [Abstract][Full Text] [Related]
20. Erosion of a new family of biodegradable polyanhydrides. Shieh L; Tamada J; Chen I; Pang J; Domb A; Langer R J Biomed Mater Res; 1994 Dec; 28(12):1465-75. PubMed ID: 7876286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]